Kyung Nam Pharm Overview
- Year Founded
-
1957
- Status
-
Public
- Employees
-
258
- Stock Symbol
-
053950
- Investments
-
5
- Share Price
-
$1.11
- (As of Friday Closing)
Kyung Nam Pharm General Information
Description
KYUNGNAM PHARM Co Ltd manufactures and markets medicines and health-aids foods. The company operates, manufactures, and sells medicines directly related to human life.
Contact Information
Website
kyungnampharm.comCorporate Office
- 79 Guryong-ro 4 nam-gil
- Uiryeong-eup
- Uiryeong-gun, Gyeongsangnam 52153
- South Korea
Corporate Office
- 79 Guryong-ro 4 nam-gil
- Uiryeong-eup
- Uiryeong-gun, Gyeongsangnam 52153
- South Korea
Kyung Nam Pharm Stock Performance
As of 13-Nov-2026, Kyung Nam Pharm’s stock price is $1.11. Its current market cap is $17.4M with 15.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.11 | $1.12 | $0.97 - $3.18 | $17.4M | 15.6M | 447K | -$0.36 |
Kyung Nam Pharm Financials Summary
As of 31-Dec-2025, Kyung Nam Pharm has a trailing 12-month revenue of $39.3M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 27,083 | 27,083 | 43,058 | 63,527 |
| Revenue | 39,310 | 39,310 | 44,555 | 45,358 |
| EBITDA | (5,158) | (5,158) | 130 | (3,633) |
| Net Income | (6,329) | (6,329) | 7,385 | (16,060) |
| Total Assets | 108,076 | 108,076 | 113,094 | 129,287 |
| Total Debt | 24,918 | 24,918 | 25,518 | 39,832 |
Kyung Nam Pharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kyung Nam Pharm Signals
Kyung Nam Pharm Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kyung Nam Pharm Investments & Acquisitions (5)
Kyung Nam Pharm’s most recent deal was a PIPE with Ascendio (Seoul) for . The deal was made on 07-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ascendio (Seoul) | 07-Jul-2026 | PIPE | Movies, Music and Entertainment | ||
| Hanju ART | 29-Dec-2023 | PIPE | Industrial Supplies and Parts | ||
| Hanju ART | 24-Mar-2023 | PIPE | Industrial Supplies and Parts | ||
| Hanju ART | 15-Mar-2023 | Secondary Transaction - Private | Industrial Supplies and Parts | ||
| Enter Partners | Merger/Acquisition | Distributors/Wholesale |
Kyung Nam Pharm ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Technology Hardware
Industry
Rank
Percentile
Electronic Components
Subindustry
Rank
Percentile
Kyung Nam Pharm FAQs
-
When was Kyung Nam Pharm founded?
Kyung Nam Pharm was founded in 1957.
-
Where is Kyung Nam Pharm headquartered?
Kyung Nam Pharm is headquartered in Uiryeong-gun, South Korea.
-
What is the size of Kyung Nam Pharm?
Kyung Nam Pharm has 258 total employees.
-
What industry is Kyung Nam Pharm in?
Kyung Nam Pharm’s primary industry is Pharmaceuticals.
-
Is Kyung Nam Pharm a private or public company?
Kyung Nam Pharm is a Public company.
-
What is Kyung Nam Pharm’s stock symbol?
The ticker symbol for Kyung Nam Pharm is 053950.
-
What is the current stock price of Kyung Nam Pharm?
As of 13-Nov-2026 the stock price of Kyung Nam Pharm is $1.11.
-
What is the current market cap of Kyung Nam Pharm?
The current market capitalization of Kyung Nam Pharm is $17.4M.
-
What is Kyung Nam Pharm’s current revenue?
The trailing twelve month revenue for Kyung Nam Pharm is $39.3M.
-
What is Kyung Nam Pharm’s annual earnings per share (EPS)?
Kyung Nam Pharm’s EPS for 12 months was -$0.36.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process